Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • How big is the problem?
    • How we drive change
    • Our story
  • Featured insights
    • The latest at the Foundation
    • The latest at the Foundation
  • Sectors and research
    • Big pharma
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
    • Big pharma
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
  • Become a catalyst
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
  • Achievements so far
    • The Foundation's impact
    • The Foundation's impact
  • News
  • Our team
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us
Featured insights

The latest at the Foundation

Insights from our industry-shifting research and analysis, coverage in the international media, events, and all the latest from the Access to Medicine Foundation.
Event

MPP Strategy Launch Event: Jayasree K. Iyer to speak on the expansion of novel medical technologies

30 January 2023
News

Foundation names Expert Committee for the Generic Medicine Manufacturers Research Programme

25 November 2022
Research

Investor Action on Antimicrobial Resistance progress report

21 November 2022
News

Drugmakers that dominate the world's insulin market must scale up access efforts globally

06 October 2022
Featured News

Index finds more pharma companies moving to address access to medicine. Will they now go further?

15 November 2022

Resource Center

Read the best practices and findings from 2022 Access to Medicine Index
Featured Key findings

Some companies engaging in R&D for emerging infectious diseases, but pipeline mainly empty

15 November 2022
Key findings

First voluntary licence for a cancer treatment is a promising sign for future expansion of access to innovative medicines

15 November 2022
Featured Key findings

More access plans and strategies to expand access to more products, but with limited breadth and depth

15 November 2022
Research

Implementing strong access strategies across different country income classifications

15 November 2022
2022 Ranking

GSK in top spot, Johnson & Johnson close second. AstraZeneca leaps up to join the top three. Bayer and Merck climb the Index ranking.

Read more
News

Drug makers must address access to antibiotics to help slow the superbug threat

09 June 2022
Event

International Conference on Public Health in Africa: Building more resilient health systems

13 December 2022
Research

Are pharma companies addressing sexual and reproductive health access barriers for women and girls?

18 November 2022

Achievements so far

Read more about the Foundation's impact
Event

Closing the gaps in access to diabetes care in low- and middle-income countries

07 July 2022
News

Global oxygen suppliers commit to closing oxygen gaps in low- and middle-income countries

16 June 2021

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Copyright 2004 - 2022 Access to Medicine Foundation - All Rights Reserved